Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 301 through 310 of 424 results (Download Results)

Show results per page

Post-Acute Sequelae of COVID-19: An Electroencephalography and Magnetic Resonance Neuroimaging Study of the Elderly in our Communities

Graham, Simon J | Sunnybrook Research Institute | Operating Grant | $500,000

CIHR Ontario 2021

Sexual Health and STI Prevention For Men Who Have Sex with Men (MSM) In Suburban Cities

Gesink, Dionne | Moyo Health and Community Services | Project Grant | $393,975

CIHR Ontario 2021

COVID-19 Variant Supplement – A behavioural science approach to evaluate the prevalence and predictors of COVID-19-related mental health issues and maladaptive behavioural coping (MBC) to inform the development of strategies for tailored interventions

Bacon, Simon L | CIUSSS du Nord-de-l'Ile-de Montréal - Hôpital Sacré Coeur | Operating Grant | $42,000

CIHR Quebec 2021

Evaluation of COVID‑19 antibodies, cell-mediated immunity and telomeres following COVID‑19 immunization or natural infection in an immune compromised population: An HIV Cohort Study

Gill, Michael J | The University of Calgary | Operating Grant | $434,655

CIHR Alberta 2021

Post COVID hyperinflammation: A syndrome beyond the name

Yeung, Rae S | Hospital for Sick Children | Operating Grant | $499,170

CIHR Ontario 2021

Feeding EPA and DHA Improve Clinical Symptoms Associated with COVID‑19 Infection

Mazurak, Vera C | University of Alberta | Project Grant | $344,250

CIHR Alberta 2021

COVID-19 Variant Supplement – Rapid development of antiviral compounds to fight the COVID‑19 outbreak

Sidhu, Sachdev S | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Implementation of serological and molecular tools to inform COVID‑19 patient management

Lerner-Ellis, Jordan P | Sinai Health System | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

Wilson, Joyce A | University of Saskatchewan | Operating Grant | $50,000

CIHR Saskatchewan 2021

Developing wise practices for a culturally safe rapid public health response to COVID‑19 with Pikwàkanagàn First Nation

Gifford, Wendy A | University of Ottawa | Other | $200,000

CIHR Ontario 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Post-Acute Sequelae of COVID-19: An Electroencephalography and Magnetic Resonance Neuroimaging Study of the Elderly in our Communities

Sexual Health and STI Prevention For Men Who Have Sex with Men (MSM) In Suburban Cities

COVID-19 Variant Supplement – A behavioural science approach to evaluate the prevalence and predictors of COVID-19-related mental health issues and maladaptive behavioural coping (MBC) to inform the development of strategies for tailored interventions

Evaluation of COVID‑19 antibodies, cell-mediated immunity and telomeres following COVID‑19 immunization or natural infection in an immune compromised population: An HIV Cohort Study

Post COVID hyperinflammation: A syndrome beyond the name

Feeding EPA and DHA Improve Clinical Symptoms Associated with COVID‑19 Infection

COVID-19 Variant Supplement – Rapid development of antiviral compounds to fight the COVID‑19 outbreak

COVID-19 Variant Supplement – Implementation of serological and molecular tools to inform COVID‑19 patient management

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

Developing wise practices for a culturally safe rapid public health response to COVID‑19 with Pikwàkanagàn First Nation